Initial evaluation of [(18)F]-FACBC for PET imaging of multiple myeloma

por Morath, Volker, Heider, Michael, Mittelhäuser, Markus, Rolbieski, Hannes, Stroh, Jacob, Calais, Jérémie, Eiber, Matthias, Bassermann, Florian, Weber, Wolfgang A.
Publicado 2022

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma

por Stroh, Jacob, Seckinger, Anja, Heider, Michael, Rudelius, Martina, Eichner, Ruth, Schick, Markus, Slawska, Jolanta, Emde-Rajaratnam, Martina, Salwender, Hans, Bertsch, Uta, Goldschmidt, Hartmut, Weisel, Katja, Scheid, Christof, Keller, Ulrich, Hose, Dirk, Bassermann, Florian
Publicado 2022

Actionable loss of SLF2 drives B‐cell lymphomagenesis and impairs the DNA damage response

por Zhang, Le, Wirth, Matthias, Patra, Upayan, Stroh, Jacob, Isaakidis, Konstandina, Rieger, Leonie, Kossatz, Susanne, Milanovic, Maja, Zang, Chuanbing, Demel, Uta, Keiten‐Schmitz, Jan, Wagner, Kristina, Steiger, Katja, Rad, Roland, Bassermann, Florian, Müller, Stefan, Keller, Ulrich, Schick, Markus
Publicado 2023

The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma

por Heider, Michael, Eichner, Ruth, Stroh, Jacob, Morath, Volker, Kuisl, Anna, Zecha, Jana, Lawatscheck, Jannis, Baek, Kheewoong, Garz, Anne-Kathrin, Rudelius, Martina, Deuschle, Friedrich-Christian, Keller, Ulrich, Lemeer, Simone, Verbeek, Mareike, Götze, Katharina S., Skerra, Arne, Weber, Wolfgang A., Buchner, Johannes, Schulman, Brenda A., Kuster, Bernhard, Fernández-Sáiz, Vanesa, Bassermann, Florian
Publicado 2021